Details
| Name | R95X |
| Type | somatic mutation |
| Species | Homo sapiens |
| Tissue | blood samples |
| Experiment Method | qPCR |
| Up/Down | NA |
| Pro/Anti | Anti |
| Funtion Description | The frequency of those with one or two C9-R95X variants was lower in neovascular age-related macular degeneration (2.02%) than in PCV (5.71%) and controls (6.05%). The presence of C9-R95X conferred a 4.7-fold reduction (95% confidence interval, 1.2-18.1; |
| Regulation Gene | C9-R95X |
| Year | 2012 |
| Pubmed ID | 22190594 |
| Title | C9-R95X polymorphism in patients with neovascular age-related macular degeneration |
| Drug | NA |
| Disease | age-related macular degeneration;polypoidal choroidal vasculopathy |
| Environment Factors | NA |
| Circulating | 1 |
| Variant | somatic mutation |
| High-throughput | NA |